Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO
NCT06276010
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Extracorporeal Membrane Oxygenation Complication
Interventions
DRUG:
nafamostat mesilate
DRUG:
unfractionated heparin group
Sponsor
Xiaotong Hou